Showing 461-470 of 1059 results for "".
Evolution in Dermatology/Industry Partnerships
https://practicaldermatology.com/topics/practice-management/evolution-in-dermatologyindustry-partnerships/23295/The COVID-19 crisis is changing the dermatology industry. What does it mean?New Products/New In My Practice: OTC
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-productsnew-in-my-practice-otc-6/23222/Women in Dermatology With Brooke Jackson, MD
https://practicaldermatology.com/topics/practice-management/women-in-dermatology-with-brooke-jackson-md/23218/Building Dermatology Patient Relationships with AI Chat and Text Messaging
https://practicaldermatology.com/topics/practice-management/building-dermatology-patient-relationships-with-ai-chat-and-text-messaging/23188/Automated communication tools could actually be the secret to a personal touch.Women in Dermatology With Vivian Bucay, MD
https://practicaldermatology.com/topics/practice-management/women-in-dermatology-with-vivian-bucay-md/23153/Physician Spotlight: Roy Geronemus, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-roy-geronemus-md/23151/Microbiome in Practice: Assessing OTC Options
https://practicaldermatology.com/topics/atopic-dermatitis/microbiome-in-practice-assessing-otc-options/23123/There’s still much to learn, but clinicians already have tools to manipulate the microbiome.Biologics for Psoriasis: A Status Update
https://practicaldermatology.com/topics/psoriasis/biologics-for-psoriasis-a-status-update/23006/The field has grown substantially from the early 2000s to include now a dozen innovator systemic agents, a host of biosimilars, and soon JAK Inhibitors.Dermatologic Disparities: Essential Considerations in Patient Care
https://practicaldermatology.com/topics/skin-of-color/dermatologic-disparities-essential-considerations-in-patient-care/22987/A brief review of dermatologic healthcare disparities in the lesbian, gay, bisexual, and transgender (LGBT) community and racial minority groups, including African Americans, Hispanics, and Asian/Pacific Islanders.Micromanagement: Microparticles Enhance Outcomes of Energy-based Acne Care
https://practicaldermatology.com/topics/general-topics/micromanagement-microparticles-enhance-outcomes-of-energy-based-acne-care/20384/With recent FDA-clearance, microparticles are available to support Nd:YAG based treatment of inflammatory acne.